| EGLN3 |
cytoplasm |
GO:0005737 |
| EGLN3 |
cytosol |
GO:0005829 |
| EGLN3 |
nucleoplasm |
GO:0005654 |
| EGLN3 |
nucleus |
GO:0005634 |
| EGLN3 |
2-oxoglutarate-dependent dioxygenase activity |
GO:0016706 |
| EGLN3 |
ferrous iron binding |
GO:0008198 |
| EGLN3 |
L-ascorbic acid binding |
GO:0031418 |
| EGLN3 |
peptidyl-proline 4-dioxygenase activity |
GO:0031545 |
| EGLN3 |
peptidyl-proline dioxygenase activity |
GO:0031543 |
| EGLN3 |
activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0006919 |
| EGLN3 |
apoptotic process |
GO:0006915 |
| EGLN3 |
cellular response to DNA damage stimulus |
GO:0006974 |
| EGLN3 |
cellular response to hypoxia |
GO:0071456 |
| EGLN3 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline |
GO:0018401 |
| EGLN3 |
protein hydroxylation |
GO:0018126 |
| EGLN3 |
regulation of cell population proliferation |
GO:0042127 |
| EGLN3 |
regulation of neuron apoptotic process |
GO:0043523 |
| EGLN3 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
GO:0061418 |
| EGLN3 |
response to hypoxia |
GO:0001666 |